Allurion presents data on the allurion balloon and ai-powered virtual care suite with and without glp-1s to optimize muscle mass and increase weight loss

Natick, mass.--(business wire)---- $alur--allurion technologies, inc. (“allurion” or the “company”) (nyse: alur), a pioneer in metabolically healthy weight loss, today announced the presentation of four abstracts at the european congress on obesity (eco) taking place in malaga, spain, may 11-14, 2025. these studies highlight the transformative impact of the allurion balloon and the virtual care suite (vcs)—the ai-powered digital platform that includes coach iris—on weight loss outcomes and lean body mass.
ALUR Ratings Summary
ALUR Quant Ranking